Checked by Francois Grillet and Kay M.
Brummond.
1. Procedure
2. Notes
1.
Lithium chloride was flame dried under vacuum for 10 min.
All glassware is dried overnight at 95 °C prior to use.
All reactions are run under 1 atmosphere of argon.
All solvents and reagents are added via syringe through a rubber septum.
All reagents are purchased from Sigma Aldrich and used as received unless another vendor or method of purification is specified below.
The purity of 3-butyn-2-ol used was 97%.
Anhydrous 99.9%, inhibitor free tetrahydrofuran was purchased from Aldrich and purified with alumina using the Sol-Tek ST-002 solvent purification system directly before use.
The submitters report that reagent grade tetrahydrofuran was freshly distilled from sodium/benzophenone ketyl under an atmosphere of dry nitrogen.
2.
The submitters report that the three-step reaction sequence can be performed on a 150-mmol scale with similar yields and stereocontrol.
3.
Significant quantities of salts are formed during this reaction, so efficient stirring is crucial.
4.
Phenyldimethylchlorosilane is purchased from Gelest and used as received.
5.
The column was packed with 275 g of silica gel, then 500 mL of hexanes followed by 500 mL of 5% ethyl acetate/hexanes are used to elute unreacted silane (R
f = 0.95, 20% ethyl acetate/hexanes), followed by 4 L 10% ethyl acetate/hexanes .
Fractions were collected using 50 mL test tubes, the product has an R
f = 0.40 in 20% ethyl acetate/hexanes, and stains strongly with potassium permanganate.
Alcohol (
2) exhibits the following characteristics:
1H NMR
pdf(300 MHz, CDCl
3) δ: 0.42 (s, 6 H), 1.49 (d,
J = 6.6 Hz, 3 H), 1.96 (m, 1 H), 4.56 (m, 1 H), 7.37 - 7.39 (m, 3 H), 7.60 - 7.63 (m, 2H);
13C NMR
pdf(150 MHz, CDCl
3) δ: -1.0, 24.1, 58.6, 86.2, 109.4, 127.9, 129.4, 133.6, 136.6; IR (film) υ
max 3330, 3076, 2978, 2181,
1429 cm
−1; HRMS (CI, NH
3)
m/z calcd for C
12H
17OSi [M+H]
+ 205.1049, found: 205.1040; Anal.
calcd.
for C
12H
16OSi: C, 70.53, H, 7.89.
Found: C, 70.30, H, 7.79.
6.
When the reaction was performed at half-scale, 6.9 g (90%) of product was isolated.
7.
Lipase AK is purchased from Amano Enzyme Inc.
The lipase is washed with
diethyl ether (50 mL), filtered and air dried for 30 min immediately before use.
8.
Small aliquots of the solution are removed and filtered through a cotton plug to remove traces of enzyme.
The filtrate is concentrated under vacuum, and a
1H NMR of the residue is taken.
The reaction is judged complete when the integral ratios of the resonances for the protons alpha to the alcohol (δ 4.55) and alpha to the acetate (δ 5.52) are equal, typically requiring 15-20 h.
9.
The column was packed with 400 g of silica gel.
Elution with 2.5 L of 5% ethyl acetate/hexanes affords acetate
3 (R
f = 0.60, 20% ethyl acetate/hexanes).
The first 1.0 L of eluent is collected in 250 mL fractions, followed by 50 mL fractions.
Next, elution with 4.2 L of 10% ethyl acetate/hexanes is used to collect alcohol ((
S)-
2), 50 mL fractions are collected throughout, (R
f = 0.40 in 20% ethyl acetate/hexanes and stains strongly with potassium permanganate).
Enantioenriched alcohol ((
S)-
2) exhibits the following characteristics:
1H NMR
pdf(600 MHz, CDCl
3) δ: 0.43 (s, 6 H), 1.47 (d,
J = 6.6 Hz, 3 H), 1.93 (m, 1 H), 4.56 (m, 1 H), 7.26 - 7.40 (m, 3H), 7.62 - 7.63 (m, 2 H);
13C NMR
pdf(150 MHz, CDCl
3) δ: -1.0, 24.1, 58.6, 86.3, 109.4, 127.9, 129.4, 133.6, 136.6; IR (film) υ
max 3342, 3064, 2982, 2177, 1429 cm
−1; HRMS (CI, NH
3)
m/z calcd for C
12H
17OSi [M+H]
+ 205.1049, found: 205.1051; Anal.
calcd.
for C
12H
16OSi: C, 70.53, H, 7.89.
Found: C, 70.25, H, 7.97; [α]
20D-11.2 (c 5.5, CH
2Cl
2).
10.
When the reaction was performed at half-scale, 3.31 g (49%) of product was isolated.
The checkers established the enantiomeric purity of ((
S)-
2) by HPLC analysis
(Note 17) run on a Chiralpak IB-3 column eluting in 0.5% 2-propanol/hexanes, with a 2.0 μL injection and a 1.0 mL/min flow rate.
The alcohol has >98% ee.
The peaks are visualized at 210 nm, with the racemic alcohol
2 exhibiting equal peaks with retention times of 11.6 and 12.6 min, and the enantioenriched alcohol ((
S)-
2) exhibiting a major peak with a retention time of 12.8 min (minor enantiomer has a retention time of 11.9 min).
The submitters established the enantiomeric purity of the alcohol using a dilute solution (~0.2 mg/mL, it can be difficult to see baseline separation otherwise).
HPLC is run on a ChiralCel OD column eluting in 1% 2-propanol /hexanes, with a 10 μL injection and a 1.0 mL/min flow rate.
The alcohol has >95% ee.
The peaks are visualized at 254 nm, with the racemic alcohol
2 exhibiting equal peaks with retention times of 18.1 and 19.5 min, and the enantioenriched alcohol ((
S)-
2) exhibiting a major peak with a retention time of 19.2 min (minor enantiomer has a retention time of 18.4 min).
Enantioenriched acetate ((
R)-
3) exhibits the following characteristics:
1H NMR
pdf(300 MHz, CDCl
3) δ: 0.42 (s, 6 H), 1.51 (d,
J = 6.9 Hz, 3 H), 2.08 (s, 3 H), 5.51 (m, 1 H), 7.37 - 7.39 (m, 3 H), 7.60 - 7.63 (m, 2 H);
13C NMR
pdf(150 MHz, CDCl
3) δ: -1.2, 20.7, 21.2, 60.3, 87.1, 105.3, 127.7, 129.3, 133.4, 136.2, 169.2; IR (film) υ
max 3068, 2991, 2954, 2178, 1744, 1434, 1364 cm
−1; HRMS (CI, NH
3)
m/z calcd for C
14H
19O
2Si [M+H]
+ 245.0998, found: 245.1018; Anal.
calcd.
for C
14H
18O
2Si: C, 68.25, H, 7.36.
Found: C, 68.53, H, 7.21; [α]
20D+ 100 (7.4, CH
2Cl
2).
Determination of the enantiomeric excess of the acetate required the synthesis of the racemic acetate (
±)-
3 (Scheme 1).
Scheme 1. Acetylation of racemic alcohol
Alcohol
(±)-2 (523 mg, 2.56 mmol, 1 equiv) is dissolved in CH
2Cl
2 (10 mL) and 4-(dimethylamino)pyridine (32 mg, 0.256 mmol, 0.1 equiv), triethylamine (3.57 mL, 2.59 g, 25.6 mmol, 10 equiv) and
acetic anhydride (1.2 mL, 1.31 g, 12.7 mmol, 5 equiv) are added in that order.
The resulting solution is stirred at room temperature for 12 h, diluted with ammonium chloride (10 mL), filtered through a Celite plug and rinsed with CH
2Cl
2 (50 mL).
The phases are separated and the aqueous layer is extracted with CH
2Cl
2 (2 × 30 mL).
The combined organic layers are washed with brine (20 mL), dried over Na
2SO
4 (5 g), filtered, concentrated under reduced pressure and purified by flash chromatography (5% ethyl acetate/hexanes) to afford racemic acetate
(±)-3 (0.493 g, 78% yield) as a colorless oil.
The checkers established enantiomeric purity by HPLC analysis
(Note 17) run on a Chiralpak IB-3 column eluting in 0.2% 2-propanol/hexanes, with a 2.0 μL injection and a 0.3 mL/min flow rate.
The acetate has >99% ee.
The peaks are visualized at 210 nm, with the racemic acetate
(±)-3 exhibiting equal peaks with retention times of 10.0 and 11.6 min, and the enantioenriched alcohol (
R)-
3 exhibiting a major peak with a retention time of 10.9 min; the minor enantiomer is not observed.
11.
Both trimethylorthoacetate and xylenes are purchased from Aldrich and used without further purification.
12.
It is critical that the bath temperature be kept at this temperature or the reaction will not go to completion.
13.
Most of the xylenes is removed using a rotary evaporator with the water bath heated to 60 °C and by using dry ice/acetone in the cooling trap, the remainder is removed during the chromatography purification step.
14.
The column was packed with 150 g of silica gel.
Hexanes (500 mL) was used to elute the xylenes (R
f = 1.0, 20% ethyl acetate/hexanes) then elution with 1.5 L of 2% ethyl acetate/hexanes afforded the product, which has an R
f = 0.85 in 20% ethyl acetate/hexanes, and stains strongly with potassium permanganate.
15.
Enantiomerically enriched allenylsilane ((
Ra)-
4) exhibits the following characteristics:
1H NMR
pdf(400 MHz, CDCl
3) δ: 0.38 (s, 6 H), 1.64 (d,
J = 7.2 Hz, 3 H), 2.93 (d,
J = 1.6 Hz, 2 H), 3.55 (s, 3 H), 4.94 (m, 1 H), 7.34 - 7.36 (m, 3 H), 7.53 (m, 2 H);
13C NMR
pdf(100 MHz, CDCl
3) δ: -3.0, -2.9, 13.2, 36.0, 51.4, 81.2, 88.4, 127.6, 129.0, 133.7, 137.4, 172.0, 209.4; IR (film) υ
max 2954, 1945, 1740, 1434 cm
−1; HRMS (EI
+)
m/z calcd for C
15H
20O
2Si [M]
+ 260.1233, found: 260.1252; [α]
20D -5.8 (c 5.7, CH
2Cl
2).
When the reaction was performed at half-scale, 3.61 g (83%) of product was isolated.
Purity (>98%) was established by HPLC analysis: ChiraCel OD column, eluent =
i-PrOH/hexane = 0.5/99.5, flow = 1 mL/min, detection = 254 nm, injection volume : 20 μL, retention time = 4.39 mi (major isomer).
16.
To determine the enantiomeric excess of allenylsilane (
Ra)-
4 the methyl ester was reduced to a primary alcohol using lithium borohydride (Scheme 2).
Scheme 2. Reduction of Methyl Ester
A single-necked, 25-mL round-bottomed flask equipped with a rubber septum and a 1-inch egg-shaped magnetic stir bar is charged with
lithium borohydride (0.046 g, 2.12 mmol, 2 equiv),
diethyl ether (3 mL) and methanol (0.2 mL).
The resulting mixture is cooled to 0 °C and a solution of (
Ra)-
4 (0.27 g, 1.06 mmol, 1 equiv) in diethyl ether (3 mL) is added.
The solution is stirred for 12 h while warming slowly to room temperature.
Upon completion of the reaction, ethyl acetate (3 mL), acetone (3 mL) and water (10 mL) are added sequentially.
The aqueous layer is separated and extracted with ethyl acetate (3 × 5 mL).
The combined organic phases are washed with brine (10 mL), dried with sodium sulfate (200 mg), filtered and concentrated under reduced pressure.
Purification over silica gel (4 g) using 100 mL of 10% ethyl acetate/hexanes results in (
R)-3-(dimethyl(phenyl)silyl)hexa-3,4-dien-1-ol (
Ra)-
5 (0.204 g, 0.880 mmol, 83%) as a colorless oil.
The alcohol (
Ra)-
5 exhibits the following characteristics:
1H NMR
pdf(600 MHz, CDCl
3) δ: 0.37 (s, 6 H), 1.58 (m, 1 H), 1.64 (d,
J = 7.2 Hz, 3 H), 2.16-2.18 (m, 2 H), 3.67 (m, 2 H), 4.91 (m, 1 H), 7.35 - 7.36 (m, 3 H), 7.52 (m, 2 H);
13C NMR
pdf(100 MHz, CDCl
3) δ: -3.2,
-3.1, 13.8, 32.6, 62.2, 81.1, 91.7, 127.8, 129.2, 133.7, 137.9, 172.0, 207.3; IR (film) υ
max 3363, 3072, 2953, 2889, 1932, 1426, 1369 cm
−1; HRMS (EI+)
m/z calcd for C
14H
20OSi [M]
+ 232.1252, found: 232.1255; Anal.
calcd.
for C
14H
20OSi: C, 72.36, H, 8.67.
Found: C, 71.77, H, 8.80; [α]
20D-18.6 (c 4.9, CH
2Cl
2); R
f = 0.25 in 5:1 hexanes/ethyl acetate.
The enantiomeric excess determination required the synthesis of the racemic alcohol
(±)-5.
The procedures used for the synthesis of the racemic compound were entirely analogous to the ones used to synthesize the enantiomerically enriched alcohol (
Ra)-
5 (Scheme 3).
Scheme 3. Synthesis of the racemic alcohol
The checkers established the enantiomeric purity by HPLC analysis
(Note 17) run on a Chiralpak IB-3 column eluting in 0.5% 2-propanol/hexanes, with a 2.0 μL injection and a 1.0 mL/min flow rate.
The alcohol has >93% ee.
The peaks are visualized at 210 nm, with the racemic alcohol
(±)-5 exhibiting equal peaks with retention times of 14.2 and 15.8 min, and the enantioenriched alcohol (
Ra)-
5 exhibiting a major peak with a retention time of 12.8 min (minor enantiomer has a retention time of 11.9 min).
The submitters established enantiomeric purity of the alcohol using a ChiralCel OD column eluting in 1% 2-propanol/hexanes with a 10 μL injection and a 1.0 mL/min flow rate.
The peaks are visualized at 254 nm, with the racemic alcohol
(±)-5 exhibiting equal peaks with retention times of 14.3 and 15.8 min, and the enantioenriched alcohol (
Ra)-
5 exhibiting a major peak with a retention time of 15.7 min (minor enantiomer has a retention time of 14.6 min).
17.
Enantiomeric excess determinations reported by the checkers were performed by Chiral Technologies, Inc.
The checkers and Organic Syntheses gratefully acknowledge their assistance.
The procedures in this article are intended for use only by persons with prior training in experimental organic chemistry. All hazardous materials should be handled using the standard procedures for work with chemicals described in references such as "Prudent Practices in the Laboratory" (The National Academies Press, Washington, D.C., 2011 www.nap.edu). All chemical waste should be disposed of in accordance with local regulations. For general guidelines for the management of chemical waste, see Chapter 8 of Prudent Practices.
These procedures must be conducted at one's own risk. Organic Syntheses, Inc., its Editors, and its Board of Directors do not warrant or guarantee the safety of individuals using these procedures and hereby disclaim any liability for any injuries or damages claimed to have resulted from or related in any way to the procedures herein.
3. Discussion
Copyright © 1921-, Organic Syntheses, Inc. All Rights Reserved